glp-1 drugs and breast cancer Can You Take Ozempic with Cancer? Is It Safe for Survivors? Could GLP-1 Drugs Play a
Description
In a recent study in SH-SY5Y cells treated with 6-OHDA, both semaglutide and liraglutide protected against 6-OHDA cytotoxicity by increasing autophagy flux and decreasing oxidative stress as well as mitochondrial dysfunction, with semaglutide being superior compared to liraglutide [90]
Due to the high expression profile of GLP-1R in pancreatic -cells, GLP-1 analogs (such as exendin-4) have been modified by different methods (to prolong half-life, maintain receptor binding affinity and reduce renal drug accumulation) for theranostic purposes and serve as excellent templates for future cardiovascular drug development[178-184]

Similar reductions in serum LH were reported with GLP-1/GIP administration, while GLP-1/E treatment restored estrous cyclicity and increased the number of corpora lutea across multiple generations (Sanchez-Garrido et al., 2024)

The remarkable weight loss and glucose-lowering results achieved by the dual peptides paved the way for triple GIP/GLP-1/glucagon receptor triagonists with the hope that the new combinatorial approaches provide further synergistic metabolic effects
Most thyroid cancers identified in observational studies are papillary thyroid carcinomas, not medullary thyroid carcinoma

Ahmad Nadia, N
